First published 9/30/2026, 7:56:15 AM · Last updated 9/30/2026, 7:56:15 AM

Real-World-Ergebnisse zu Ivosidenib bei IDH1-mutierten biliären Karzinomen – Multizentrische retrospektive Analyse und Vergleich mit der TriNetX-Datenbank

Journal article reporting real-world results of ivosidenib in IDH1‑mutated biliary carcinomas from a multicenter retrospective analysis with comparison to the TriNetX database. Published by Georg Thieme Verlag KG on 2026-08-01; the excerpt provided contains no additional methodological or outcome details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 3/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 2/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article presents clinical real-world results for a targeted therapy in a defined cancer population.

Sources

Real-World-Ergebnisse zu Ivosidenib bei IDH1-mutierten biliären Karzinomen – Multizentrische retrospektive Analyse und Vergleich mit der TriNetX-Datenbank

Report an issue